Effects of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality: A Comprehensive Network Meta-analysis

被引：0
作者：
Tang, Huilin
Fang, Zhenwei
Wang, Tiansheng
Song, Yiqing
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1386-P
引用
收藏
页码：A363 / A363
页数：1
相关论文
共 50 条
[31]   Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide [J].
Simes, Bryce C. ;
MacGregor, Gordon G. .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 :2125-2136
[32]   Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection [J].
Berbari, Adel E. .
INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION, 2020, 7
[33]   Efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with acute heart failure: a systematic review and meta-analysis [J].
Hou, Jingjin ;
Ren, Li ;
Hou, Qingbin ;
Jia, Xiaodong ;
Mei, Zhu ;
Xu, Jiaxin ;
Yang, Zheming ;
Li, Yiming ;
Yan, Chenghui .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
[34]   Potential anticancer effects of sodium-glucose cotransporter protein 2 (SGLT2) inhibitors Canagliflozin and Dapagliflozin [J].
Dong, Weiyu ;
Wang, Yanyan ;
Fan, Shaohua .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
[35]   Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials [J].
Yao Neng Teo ;
Adriel Z. H. Ting ;
Yao Hao Teo ;
Elliot Yeung Chong ;
Joshua Teik Ann Tan ;
Nicholas L. Syn ;
Alys Z. Q. Chia ;
How Ting Ong ;
Alex Jia Yang Cheong ;
Tony Yi-Wei Li ;
Kian Keong Poh ;
Tiong Cheng Yeo ;
Mark Yan-Yee Chan ;
Raymond C. C. Wong ;
Ping Chai ;
Ching-Hui Sia .
American Journal of Cardiovascular Drugs, 2022, 22 :299-323
[36]   Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials [J].
Teo, Yao Neng ;
Ting, Adriel Z. H. ;
Teo, Yao Hao ;
Chong, Elliot Yeung ;
Tan, Joshua Teik Ann ;
Syn, Nicholas L. ;
Chia, Alys Z. Q. ;
Ong, How Ting ;
Cheong, Alex Jia Yang ;
Li, Tony Yi-Wei ;
Poh, Kian Keong ;
Yeo, Tiong Cheng ;
Chan, Mark Yan-Yee ;
Wong, Raymond C. C. ;
Chai, Ping ;
Sia, Ching-Hui .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) :299-323
[37]   Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats [J].
Londzin, Piotr ;
Brudnowska, Agata ;
Kurkowska, Katarzyna ;
Wilk, Katarzyna ;
Olszewska, Karolina ;
Ziembinski, Lukasz ;
Janas, Aleksandra ;
Cegiela, Urszula ;
Folwarczna, Joanna .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
[38]   Heart Failure Prognosis in Diabetic Patients on SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors: A Systematic Review and Meta-Analysis [J].
Nso, Nso ;
Emmanuel, Kelechi ;
Nassar, Mahmoud ;
Ayinde, Hakeem .
CIRCULATION, 2021, 144
[39]   No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysis [J].
Cai, Xiaoling ;
Gao, Xueying ;
Yang, Wenjia ;
Chen, Yifei ;
Zhang, Simin ;
Zhou, Lingli ;
Han, Xueyao ;
Ji, Linong .
JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04) :850-861
[40]   Sodium-glucose cotransporter 2 (SGLT2) inhibitors-induced erythropoiesis and cardiovascular events in chronic kidney patients [J].
Marques Vidas, Maria De San Miguel ;
Lopez, Paula ;
Sanchez Briales, Paula ;
Sanchez, Ana ;
Lopez Illazquez, Maria Victoria ;
Maria Portoles, Jose .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 :I1043-I1043
12345